The National Heart Center at Royal Hospital successfully performed the first precise cardiac catheterization procedure using the advanced heart pump assist device (Impella CP System).

This complex medical intervention was carried out by a highly competent Omani medical team, supported by an integrated team of nursing and technical staff. This reflects the high readiness of national cadres to handle the most complex and precise medical cases.

"Impella CP" technology is one of the latest global medical innovations. It works as a precise pump inserted via a catheter to temporarily support the heart muscle and assist it in pumping blood efficiently to the rest of the organs. This contributes to stabilizing blood circulation for critical patients, reducing risks, and levitation safety and success rates.

In this regard, Dr. Adel Al-Jabri, Head of Cardiac Catheterization Department at NHC, stated that the introduction of this technology represents a qualitative leap in the treatment of heart and artery diseases, especially for patients with high‑risk percutaneous coronary intervention (PCI) or cardiogenic shock. He explained that studies confirm its effectiveness in raising the chances of survival.

This achievement reflects the continuous development of health services in the Sultanate of Oman. It also underscores the commitment of the Royal Hospital and the Ministry of Health to localizing the latest global therapeutic technologies and harnessing them to serve citizens and residents according to the highest international quality standards.